Ironwood: Fourth Quarter Earnings Overview

Ironwood Pharmaceuticals Announces Fourth Quarter Results

Ironwood Pharmaceuticals Inc., headquartered in Boston, disclosed a fourth-quarter net loss of $2.3 million.

According to the company, this equates to a loss of $0.01 per share for the quarter.

During the same period, Ironwood generated $47.7 million in revenue.

Looking ahead, the pharmaceutical firm anticipates its annual revenue will fall between $450 million and $475 million.

Report compiled using information from Zacks Investment Research and Automated Insights.